Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSMB5 | P28074 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CSF1R | P07333 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.30 |
| ▸ | HTR7 | P34969 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172926 | 0.88 | LMNA (0.35) | MEN1KMT2AHTR1AHTR7 | |
| SCHEMBL20649848 | 0.88 | PSMB5 (0.33) | PSMB5PTGDR2PDK2PDK4 | |
| SCHEMBL20172930 | 0.84 | HTR1A (0.35) | MEN1KMT2APTGDR2HTR1AHTR7 | |
| SCHEMBL20172883 | 0.81 | HTR2C (0.33) | HTR1AHTR7 | |
| SCHEMBL21021500 | 0.80 | CYP1A2 (0.38) | — | |
| SCHEMBL20172933 | 0.80 | MEN1 (0.34) | MEN1KMT2AHTR1AHTR7 | |
| SCHEMBL21021495 | 0.80 | HTR1A (0.36) | MEN1KMT2APTGDR2HTR1AHTR7 | |
| SCHEMBL21020443 | 0.80 | PSMB5 (0.33) | PSMB5KMT2APTGDR2PDK2PDK4 | |
| SCHEMBL21982468 | 0.78 | PTGS2 (0.33) | KMT2AHTR1AHTR7 | |
| SCHEMBL20172924 | 0.78 | ADRA2A (0.34) | HTR1AHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | LG CHEM, LTD. (KR) | 2019-05-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190152919-A1 | COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME | OR10J3, ETV6, ESR1 | PSMB5 4011/4885MEN1 565/4885KMT2A 280/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.